Matches in SemOpenAlex for { <https://semopenalex.org/work/W3093095789> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W3093095789 abstract "The study examined the effect of financial distress indicators on the share price of pharmaceutical firms in Nigeria. Altman Zeta Score, operating cash flow, and debt-equity ratio were the financial distress indicators used for the study, while the share price was the dependent variable of the study. The study adopted an ex-post-facto research design, covering the period between 2009 and 2018. Secondary data were extracted from the annual reports and accounts of the sampled pharmaceutical firms in Nigeria. Simple fixed-effect regression analysis was used for the panel data analysis. In line with the specific objectives of the study which is to ascertain the effect of Altman Zeta Score, operating cash flow, and debt-equity ratio on the share price of pharmaceutical firms in Nigeria, it was revealed that Altman Zeta Score has a positive and insignificant effect on share price while operating cash flow has a positive and significant effect on the share price. However, the debt-equity ratio has a negative and insignificant effect on the share price of pharmaceutical firms in Nigeria. The study, therefore, recommended that distressed pharmaceutical firms according to the Zeta Score model should improve their management and efficiency of their employees. This is because the failures of these firms are partly caused by poor management of both resources and staff. Means of generating extra cash from operating activities should be vigorously pursued so as to increase the cash these firms generate from the issue of shares, which will help them come out of distress zone. They should reduce the rate at which they use debt to finance their activities. According to Modgliani and Miller (1963), there is a certain point at which further use of debt becomes unfavourable and continuous use of debt will increase both the agency cost and bankruptcy cost which has the implication of reducing the value of the firm leading to the likelihood of financial distress." @default.
- W3093095789 created "2020-10-22" @default.
- W3093095789 creator A5003479278 @default.
- W3093095789 creator A5070681971 @default.
- W3093095789 date "2020-06-30" @default.
- W3093095789 modified "2023-09-25" @default.
- W3093095789 title "The Effect of Financial Distress Indicators on the Share Price of Pharmaceutical Firms in Nigeria" @default.
- W3093095789 doi "https://doi.org/10.24940/theijbm/2020/v8/i6/bm2006-017" @default.
- W3093095789 hasPublicationYear "2020" @default.
- W3093095789 type Work @default.
- W3093095789 sameAs 3093095789 @default.
- W3093095789 citedByCount "0" @default.
- W3093095789 crossrefType "journal-article" @default.
- W3093095789 hasAuthorship W3093095789A5003479278 @default.
- W3093095789 hasAuthorship W3093095789A5070681971 @default.
- W3093095789 hasBestOaLocation W30930957891 @default.
- W3093095789 hasConcept C10138342 @default.
- W3093095789 hasConcept C120527767 @default.
- W3093095789 hasConcept C144133560 @default.
- W3093095789 hasConcept C149782125 @default.
- W3093095789 hasConcept C162324750 @default.
- W3093095789 hasConcept C163428354 @default.
- W3093095789 hasConcept C166819830 @default.
- W3093095789 hasConcept C17744445 @default.
- W3093095789 hasConcept C199539241 @default.
- W3093095789 hasConcept C199728807 @default.
- W3093095789 hasConcept C200870193 @default.
- W3093095789 hasConcept C2779538965 @default.
- W3093095789 hasConcept C2984760201 @default.
- W3093095789 hasConcept C556758197 @default.
- W3093095789 hasConcept C6422946 @default.
- W3093095789 hasConcept C73283319 @default.
- W3093095789 hasConceptScore W3093095789C10138342 @default.
- W3093095789 hasConceptScore W3093095789C120527767 @default.
- W3093095789 hasConceptScore W3093095789C144133560 @default.
- W3093095789 hasConceptScore W3093095789C149782125 @default.
- W3093095789 hasConceptScore W3093095789C162324750 @default.
- W3093095789 hasConceptScore W3093095789C163428354 @default.
- W3093095789 hasConceptScore W3093095789C166819830 @default.
- W3093095789 hasConceptScore W3093095789C17744445 @default.
- W3093095789 hasConceptScore W3093095789C199539241 @default.
- W3093095789 hasConceptScore W3093095789C199728807 @default.
- W3093095789 hasConceptScore W3093095789C200870193 @default.
- W3093095789 hasConceptScore W3093095789C2779538965 @default.
- W3093095789 hasConceptScore W3093095789C2984760201 @default.
- W3093095789 hasConceptScore W3093095789C556758197 @default.
- W3093095789 hasConceptScore W3093095789C6422946 @default.
- W3093095789 hasConceptScore W3093095789C73283319 @default.
- W3093095789 hasIssue "6" @default.
- W3093095789 hasLocation W30930957891 @default.
- W3093095789 hasOpenAccess W3093095789 @default.
- W3093095789 hasPrimaryLocation W30930957891 @default.
- W3093095789 hasRelatedWork W2135132676 @default.
- W3093095789 hasRelatedWork W2770382951 @default.
- W3093095789 hasRelatedWork W2900561028 @default.
- W3093095789 hasRelatedWork W2913230216 @default.
- W3093095789 hasRelatedWork W3013311379 @default.
- W3093095789 hasRelatedWork W3084897522 @default.
- W3093095789 hasRelatedWork W3093095789 @default.
- W3093095789 hasRelatedWork W3123234645 @default.
- W3093095789 hasRelatedWork W3124300845 @default.
- W3093095789 hasRelatedWork W4288071150 @default.
- W3093095789 hasVolume "8" @default.
- W3093095789 isParatext "false" @default.
- W3093095789 isRetracted "false" @default.
- W3093095789 magId "3093095789" @default.
- W3093095789 workType "article" @default.